Recall: D-0052-2027
Class II - Potentially Harmful
Class IIClassification
2026-09-29Initiated
OngoingStatus
PfizerFirm
Product
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
Reason
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Distribution
US Nationwide and Puerto Rico
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.